Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jul 06, 2026
Hologic to Webcast Presentation at the 5th Annual Evercore ISI HealthCONx Conference
08:22am, Tuesday, 22'nd Nov 2022
MARLBOROUGH, Mass.--( BUSINESS WIRE )--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29
Covid testing remains 30 percent of Hologic business: CEO
04:59am, Saturday, 19'th Nov 2022
Hologic CEO Steve MacMillan joins Closing Bell to discuss the company's recent earnings and how persistent Covid testing might continue to be as a major part of Hologic's business. MacMillan also expl
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
10:32am, Tuesday, 15'th Nov 2022
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Friday, 04'th Nov 2022
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic (HOLX) Q4 Earnings Beat Estimates, Margins Down
12:03pm, Wednesday, 02'nd Nov 2022
Lower sales of COVID-19 assays and supply chain challenges drag Hologic's (HOLX) top line down.
Hologic CEO: Forecasting conservatively while also responding to market needs
04:16pm, Tuesday, 01'st Nov 2022
Hologic CEO Steve Macmillan joins 'Closing Bell' to discuss the company's earnings bump, the unprecedented strength in demand for Hologic products and managing costs through Covid.
Hologic, Inc. (HOLX) Q4 2022 Results - Earnings Call Transcript
10:20pm, Monday, 31'st Oct 2022
Hologic, Inc. (NASDAQ:HOLX ) Q4 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO
Hologic (HOLX) Beats Q4 Earnings and Revenue Estimates
06:50pm, Monday, 31'st Oct 2022
Hologic (HOLX) delivered earnings and revenue surprises of 32.26% and 9.98%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hologic stock jumps, as execs see ‘unprecedented strength' entering new fiscal year
05:58pm, Monday, 31'st Oct 2022
Shares of Hologic Inc. HOLX, +1.30% jumped 7.5% after hours on Monday after the maker of medical equipment and technology reported better-than-expected fiscal fourth-quarter results and issued some fi
Non-COVID Diagnostics Sales to Aid Hologic (HOLX) Q4 Earnings
09:02am, Friday, 21'st Oct 2022
Hologic's (HOLX) Molecular Diagnostics sales are likely to have been affected by the significant drop in demand for COVID-19 testing.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
10:32am, Monday, 17'th Oct 2022
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
11 Stocks Are Primed To Blow Away Earnings Expectations
08:00am, Friday, 14'th Oct 2022
Want to put an S&P 500 investor in a good mood during earnings season? A huge earnings surprise would do it.
What's Happening With Hologic Stock?
11:00am, Wednesday, 12'th Oct 2022
Hologic stock (NASDAQ: HOLX), a medical devices company focused on women's health, has seen a 19% fall this year, faring slightly better than the broader S&P500 index, down 24%.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
10:32am, Tuesday, 04'th Oct 2022
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022
08:22am, Tuesday, 04'th Oct 2022
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022
